|
|
Article: HIV-VAC, Inc.'s Dr. Gordon Skinner Files Patent Application for a New HIV Vaccine.
- Article from:
- Business Wire
- Article date:
- April 2, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
TORONTO--(BUSINESS WIRE)--April 2, 2003
HIV-VAC, Inc (OTCBB:HIVV) announced today that Dr. Gordon Skinner, MD(Hons) the Director of Research of HIV-VAC and the original developer of HIV-VAC's proposed vaccine (NFU.Ac.HIV1RU1295(JM)) designed to combat HIV/AIDS, has, in conjunction with Intracell Vaccines Ltd, filed a patent application with the United Kingdom Patent and Trademark Office for a method of inhibiting the release of HIV from an HIV-infected cell. This application covers what HIV-VAC believes is a novel method of vaccine preparation and use. The proposed new vaccine will operate by a different defense ...
Related newspaper, magazine, and journal articles:
|
|
Article: AIDS Vaccine Developer HIV-VAC, Inc. Featured On ...
Business Wire;
May 19, 1999 ;
700+ words
... ... BUSINESS WIRE)--May 19, 1999-- HIV-VAC, Inc., (OTC BB:HIVC) announced ... vaccines." Clinical trials with the HIV-VAC vaccine will be underway within nine ... Hastings Communications said, "HIV-VAC, Inc. will be able to enhance the ...
|
|